marijuana Archives - Green Market Report

StaffOctober 6, 2022


The Daily Hit is a recap of cannabis business news for October 6, 2022.


Biden To Pardon Marijuana Convictions, Calls For Classification Review

President Joe Biden on Thursday announced a sweeping directive that would alter the laws surrounding cannabis and its classification as a dangerous substance, as well as grant pardons to those who suffered from the War on Drugs. In a statement, the president stated that he plans to pardon all prior federal offenses and begin an administrative review alongside Justice Department to process pardons for simple marijuana possession. Read more here.

Floridians Stocked Up On Cannabis Ahead Of Hurricane Ian

Florida operators that had to temporarily shutter last week amid Hurricane Ian’s wrath are coming back online, though some companies are still reeling from its violent landfall. With the Sept. 30 cutoff date for the fiscal third quarter, some companies could see some additional padding to earnings reports, as patients throughout the state flocked to stores early last week to stock up on medicine ahead of the storm’s arrival. Read more here.

Agrify To Help Three Companies’ Grows Go Vertical

Agrify Corporation (Nasdaq: AGFY) said that three companies have decided to operate their cultivation businesses using the company’s rapid deployment packs (RDPs) — a prepackaged, quick-to-deploy alternative to traditional grow facilities. Prairie State Cannabis LLC in Illinois, LowKey LLC in Massachusetts and MediFlora Cultivation LTD in South Africa have all elected to use the tech, which the company said is able to provide “best-in-class” cultivation capabilities in potentially as little as 60-90 days. Read more here.

Recreational Psychedelics Enters The Conversation

The medical psychedelics decriminalization efforts are growing, with now 20 different states (or cities and counties within states) either decriminalizing or working on decriminalizing psychedelics. There have been pushbacks, with complaints that some decriminalization efforts include making them the “lowest law enforcement priorities,” a ruling that still effectively criminalizes psychedelics. That same ruling applied to the decriminalization of cannabis. Read more here.

Zynerba Gets Patent For Fragile X Drug

Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders, today announced that the U.S. Patent and Trademark Office has issued Patent No. 11,458,110, titled “Treatment of Fragile X Syndrome With Cannabidiol,” which includes claims directed to methods of treating Fragile X syndrome with cannabidiol. Read more here.

Green Thumb Industries Sees Board Shakeup

Three of four independent board members of Green Thumb Industries (OTC: GTBIF), including Dorri McWhorter, resigned over what the marijuana company said was “a disagreement as to the company’s policies and practices related to personal misconduct.” Read more here.


Agrify Corporation

Agrify Corporation (Nasdaq : AGFY), a provider of cultivation and extraction solutions for the cannabis industry, today issued the following statement relating to the default of its customer Bud & Mary’s Cultivation, Inc. under a construction loan facility extended by Agrify to Bud & Mary’s associated with an Agrify Total Turn-Key Solution project and the lawsuit brought by Bud & Mary’s in response to the default notice. Read more here.

Bespoke Extracts, Inc.

Bespoke Extracts, Inc. (OTCQB: BSPK) today announced that the Colorado Marijuana Enforcement Division (MED) has approved Bespoke’s application for “suitability”. This approval enables Bespoke to acquire, subject to final state and local approval, any business licensed by the MED. Read more here.

Merchants & Marine Bank, CannaFirst Financial

Merchants & Marine Bank, a century-old Mississippi-based banking institution, has launched CannaFirst Financial, the first banking division dedicated to business owners in Mississippi’s quickly emerging cannabis industry. CannaFirst will serve clients in platform integration, online and mobile banking, cash transport, and treasury solutions. It is overseen and staffed by seasoned banking professionals with significant experience and certifications in emerging markets and industries. Read more here.

Neuraxpharm Group, Panaxia

Neuraxpharm Group, a European specialty pharmaceutical company focused on the central nervous system, and Panaxia (TASE: PNAX), a global pharmaceutical company that develops, manufactures and markets advanced medical cannabis products of pharmaceutical quality, today announced the signing of two addendums to their agreement to expand their collaboration into the Czech and Swiss markets. Read more here.

F1SeedTech, NewBreedSeed

F1SeedTech and NewBreedSeed (NBS) announced that they have entered into a definitive agreement, with F1SeedTech acquiring 100% of the shares of NBS. The merger creates the industry leader in F1 hybrid varieties of cannabis, combining the day-neutral breeding activities of NBS and the short-day breeding activities of F1SeedTech in Israel and the Netherlands, respectively. Read more here.

Optimi Health Corp.

Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian-based company licensed by Health Canada to produce and supply natural, EU-GMP grade psilocybin and other psychedelic substances, most notably MDMA, is applauding the government of Alberta’s decision to regulate some psychedelics for therapeutic use in the province. Read more here.

Cybin Inc.

Cybin Inc. (NEO:CYBN) (NYSE AMERICAN:CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics®, provided an update on its intellectual property progress in support of its research and development strategy. The company continues to prioritize the development of in-house IP and licensing opportunities that support its active development programs and future novel drug candidates. Read more here.

StaffFebruary 19, 2021


Editors Note: This is a guest post.

Cannabis is a big business. Consumer spending in the US is set to rise by $13bn in the four years from 2018, as legalization hits more states and the medical cannabis sector continues to thrive. Analysis of this booming trade indicates that medical marijuana dispensaries are turning over more money per square foot of retail space than Apple Stores and Tiffany’s.

One consequence of this incredible increase in activity is the innovations and advancements in how marijuana is consumed. These new consumption methods have opened the doors of the marijuana world to a whole new audience, especially those who are consuming cannabis for medicinal purposes. 

For those new to cannabis, and even for seasoned veterans, these new methods can be confusing. As a whole new host of devices and modes of delivery hit the market, they bring new questions. So read on as we breakdown some of the most popular ways to introduce THC into your system.


You may already be familiar with vaping and e-cigarettes from the craze that took hold a few years ago touted as a healthy alternative to smoking tobacco and a stepping stone to quitting nicotine altogether. 

Hot on the heels of nicotine vapes are cannabis vaporizers. There are many different ways to vape cannabis and a whole host of devices to match. One of the most popular is the dry herb vaporizer, a device that heats cannabis flower just enough to release THC but not so much that the bud combusts and releases toxin-filled smoke. Brands like Pax continue to push the boundaries of the dry herb vaporizer technology, such is the case with their new Pax 3 which can be seen here. This dry herb vaporizer allows the marijuana to be heated up in just 15 seconds and is roughly the same size as an average cigarette lighter.

Some vaporizers are specifically designed for concentrates like shatter and wax, and some devices use cannabis e-liquid – similar to nicotine vapes. 

Like smoking a joint, the high from vaping hits almost instantly, and many users have reported that the feeling is more crisp and clear than highs from other consumption methods. 

Joints and Bongs

The cannabis industry can develop a million consumption innovations, but joints and bongs are here to stay. Smoking weed in a joint is the most iconic and well-known way to get stoned. A joint consists of ground cannabis flower wrapped in cigarette paper and smoked like a traditional cigarette. They can be made with or without the addition of tobacco – this is down to personal preference. Many cannabis uses love the ritual of sitting down and rolling a joint and the tactile experience it provides. 

The bong is another popular and age-old way of getting a marijuana hit. Sometimes known as a bowl or water pipe, a bong is a device where the user burns the marijuana and inhales through a mouthpiece. The smoke is pulled down through a tube and bubbles up through water at the bottom of a chamber, which cools it down and makes it easier to inhale.

Although both of these methods are as old as they get, they are increasingly thought of as the most unhealthy way to consume cannabis, as many toxins and chemicals are released from the weed when it burns. The high from joints and bongs is instantaneous. 


Edibles have exploded onto the cannabis scene in recent years. An edible is a food or drink that has been infused with cannabis. Edibles come in all shapes and sizes, everything from brownies, cookies, chocolate bars, soft drinks, and even potato chips and maple syrup. The opportunities here are endless – anything you can eat can be infused with cannabis in one way or another. 

Edibles are a great alternative to smoking and vaping, as there is no risk of lung damage. They are a common entry point for cannabis newbies as they are seen as one of the softest forms of consumption. Because the food must be broken down in the stomach before the THC reaches the bloodstream, the effects can take anywhere from thirty minutes to two hours to kick in. 

Tinctures and Topicals

Tinctures and topicals are relatively new forms of administering cannabis that have been borrowed from the sister world of CBD. Tinctures are oil dissolved with cannabis extract. The oil can be dropped on food or in a drink or simply applied under the tongue. The effects are not as instantaneous as smoking and vaping, but not as delayed as edibles – usually around 15-20 minutes.

Topicals refer to any method where a product is applied to the skin. Topicals are mainly associated with CBD products designed to give health benefits such as clearer skin, relief from muscle pain, and stronger hair. 

StaffFebruary 19, 2021


Editor’s Note: This is a guest post.

In the past few years, there has been one major central theme debated heavily by society. That is the legalization of cannabis. The once demonized plant stigmatized to cause delusions and murderous tendencies have been finally revisited and approved by government officials. As the health benefits of cannabis become more prominent, more and more stares are starting to legalize it.

In fact, legal cannabis has been taking over the market and skyrocketing in growth. During its first year of legalization in Colorado, the state earned over 700 million dollars in tax revenue. The number has since grown to more than a billion dollars a year.

The industry is now considered a mega-giant, catering to those who need it for both medical and recreational purposes. However, there is a lot more to be said about this. If you are wondering about the ins and outs of the cannabis industry and how it became such a profitable industry virtually overnight, then here are a few points to keep in mind.

A large market of products

One of the bigger reasons why cannabis has become an incredibly popular resource is the incredibly wide range of products that are available in the market right now. 

Thanks to technological advancements since the advent of legal cannabis, users are no longer only given the choice of a few ways to smoke, such as joints, water bongs and pipes, but can do so if they still choose. Many online head shops, such as Smoke Cartel, still sell water bongs, as well as the accessories needed for them, which can be viewed here. The market is so large that there are even bongs and dab rigs that look like pieces of art, which have now been labeled luxury marijuana products.

Now, there exist state-of-the-art wax vaporizers which are bound to give you a long-lasting buzz from a quick odorless hit. There are also dry herb vaporizers for the people who still enjoy the feeling of smoking.

Even for those that do not smoke, there are many new ways for them to feel the effects of cannabis. For example, cannabis edibles come in all shapes and sizes, such as ChronTella which is an infused Nutella mix, cannabis lollipops, gummy bears, and more traditionally, cookies and brownies.

For those that do not want to eat nor smoke their dry herb, there is also an option for this demographic. Through the use of tinctures, everyone can enjoy the calming effects of cannabis with a single drop of concentrate under their tongue.

With all these new inventions, cannabis is not just about smoking anymore, it is incredibly inclusive to people from all walks of life.

There are a ton of benefits

One of the biggest reasons why cannabis was legalized is because of its anti-cancer properties. However, that is not the only thing cannabis is good for. Almost like a cure all, the plant offers a ton of medical benefits to users. For example, it is well known to reduce anxiety for many people as it offers a calming effect. Medical cannabis is also proven to have properties that combat and treat mental disorders such as Tourette syndrome, PTSD, eating disorders, depression, insomnia and many more.

The vast number of medical benefits makes it incredibly appealing to many people. Because of this, the medical marijuana industry has particularly benefited from this and it has allowed people suffering from various conditions to find relief.

A lot of people smoke

You might be surprised to hear, but a lot of people smoke. In fact, a poll done in 2020 suggests that up to 25% of US citizens have admitted to using cannabis on a regular basis. ¼ of the US enjoys the herb, and if infrequent users are added into the mix, then this percentage goes much higher.

Moreover, the number of users has only been continuously increasing as more and more cannabis dispensaries, lounges and paraphernalia shops are starting to pop out all around the country. Also, as the stigma relating to cannabis has been proven a false lie by the government, it serves as a bolster to further empower many people’s new outlook on the drug.

It is not only about THC

Cannabis is not just about getting high. There is so much more to just THC, namely CBD, which is the main component of cannabis’ health benefits. It is being use in a variety of ways other than treating mental illnesses. For example, CBD is used in skincare products, topicals, creams for sores and much more. Furthermore, CBD is not psychoactive, so it is more widely available than marijuana as it does not necessarily break drug laws.


Video StaffAugust 30, 2019


We have just two weeks to go until the Green Market Summit called The Economics of Branding in Los Angeles on Sept. 11-12. Go to www.greenmarket for tickets. You’ll see CNBC’s Jane Wells interview PLUS products CEO Jake Heimark talk about the importance of creating your brand, while singer Melissa Etheridge makes an appearance on a panel about celebrity branding. You won’t want to miss this deep dive conference.

Ok, moving on to the news. There were lots of earnings this week as we close out summer and from many of the major players in the industry. We’ll hit the highlights here.

Green Thumbs Industries of GTI said its second-quarter revenue increased 228% to $44.7 million and jumped 60% sequentially. GTI also closed this week on its purchase of NY cannabis company Fiorello Pharmaceuticals. Still, GTI delivered a net loss of $22.2 million versus a net loss of $9.7 million in the first quarter.

TILT Holdings delivered revenue of $39 million in its second-quarter but also reported a whopping net loss of $48.9 million.

Curaleaf Holdings reported revenue of $35.25 million in its second-quarter as its net loss came in at $24.5 million.

iAnthus delivered second-quarter revenues of $19.2 million, an increase of 100% as the company trimmed its net losses to $9.3 million from $16.5 million in the first quarter.

Slang Worldwide delivered second-quarter revenue that increased sequentially by 44% to $7.2 million better yet, Slang reported a net income of $17.5 million in the quarter versus a net loss of $13 million for 2018 as options valuations increased.

Tilray announced it was buying the Alberta dispensary chain Four20 in a deal valued at C$110 million. Four20 has 6 licensed retail stores and an additional 16 locations available.

Hound Labs raised $30 million for a dual-purpose breathalyzer that tests for alcohol and cannabis.

This weekend is Labor Day and markets will be closed on Monday. Everyone enjoy your three day weekend.

William SimpsonJuly 17, 2018


With President Trump signaling his likely support for the bipartisan Congressional effort to ease the U.S. ban on cannabis in legal markets, the country as a whole could benefit immensely.

By giving states the rights to determine the best course with cannabis, business valuations could go through the roof. For example, under the current laws, Golden Leaf Holdings, a cannabis company with cultivation, production, and retail operations that is publicly traded in Canada, is unable to be publicly traded on the Nasdaq. Conversely, Canadian cannabis companies are already allowed on the Nasdaq, giving them a significant advantage in the globally booming market.

The most significant progress for businesses would come with the easing of Internal Revenue Code 280E, which has, by and large, blocked cannabis businesses from tax deductions, credits and banking in general. The passing of this bill would be a tremendous step for states with legalized markets. American cannabis entities struggle daily to make retail an efficient platform, while barely breaking even under the current regulations. The Treasury Department demanding money from a market they deem illegal needs to end.

Most significantly, ending the federal ban could represent a step in the right direction towards addressing systemic criminal justice issues that unjustly target minorities, which is far more important than any business-related outcome.

This measure is far from a single, fix-all solution. Even if the bill became law tomorrow, businesses wouldn’t be able to reap the benefits right away. If cannabis remains a Schedule 1 narcotic, banks will continue to be hesitant to opening accounts for businesses. The same goes for standard business practices like shipping across state lines.

Furthermore, nothing federally-approved changes local and state laws. This means issues stemming from occupancy, zoning, packaging and other regulations will still loom over businesses. Too many voices in cannabis could leave the industry at the whim of political agendas and powerful competitor lobbies, including tobacco, alcohol and pharma.

While the bipartisan bill does provide the U.S. a step in the right direction for both the cannabis industry and its citizens, we must remember that it still is just one incremental step in the process. Plenty of work is left to be done on federal, state and local levels to revise regulations for businesses and citizens in states with legal markets. That said, the possible passing of the bill should be championed for the huge victory it would represent. With hope, it would be far from the last one to come.


Jack SmithMay 23, 2018


BDS Analytics has issued a new report on the public attitude towards marijuana in Colorado and there has been a strong movement towards more positive perception, as the state continues to embrace its cannabis culture.

The study, which was conducted from Jan. 16, 2018-Feb. 13, 2018 and ensured all participants were 21 or older, noted there has been “a substantial increase” in Colorado adults consuming marijuana, compared to the first-quarter of 2017. The researchers also found that adults were more open to exploring cannabis in different forms, though they did have prior cannabis experience or were open to using it in the future.

Colorado continues to be among the few states with legalized marijuana for recreational use and it’s clear its residents are taking advantage of that. The state saw a 12 percent increase in dollar sales year-over-year from the first-quarter of 2017 to the first quarter of 2018, according to retail sales that BDS tracks.

Among those who are consuming, BDS found Colorado’s consumers as skewing slightly older and more likely to be male. The consumers are also more likely to see it as medicine, consider themselves “connoisseurs” and claim that cannabis is part of their everyday routine.

There’s also been a shift in using it towards health and wellness benefits, especially for pain management and belief.

Here are 9 of the most interesting facts from BDS Analytics’ findings about the Colorado cannabis market.

1. Consumption is going up.

BDS found that 35 percent of Colorado residents consumed marijuana in the first-quarter of this year, as opposed to just 25 percent in the first-quarter of last year.

2. Rejectors are less likely to support it now.

Marijuana became legal to purchase in Colorado in 2014 for anyone over the age of 21 for any purpose, making it the first place in the world to have that distinction. Since then, however, rejectors have become more entrenched in their thinking.

Just 63 percent of rejectors would support legalization now, compared to compared to 80 percent in the first-quarter of 2017. In total, 85 percent of respondents think there should be some form of legal marijuana use. Perhaps not surprisingly, 99 percent of consumers who’ve used marijuana in the past six months think it should be legal in some form.

3. Health benefits.

Sixty-eight percent now believe marijuana has some health benefits, including 68 percent who believe it can relieve pain, 61 percent believe it can help with the side effects of chemotherapy and 55 percent believe minors should use it if okayed by a doctor and with parental consent.

4. Relaxation usage going down.

People who said they were using it for relaxation benefits went down year-over-year. Thirty percent said they were using it for relaxation (things like managing anxiety or stress) in the first-quarter, compared to 34% in the first-quarter of 2017.

5. An evening hit.

Consumption of marijuana is favored mostly in the evening, though the study noted that consumers are partaking in their usage throughout the day.

6. Methods are shifting.

The way people are consuming marijuana is shifting, if just a bit. They continue to prefer inhaling it, but topical use is also growing. 79 percent of consumers inhaled it in the first-quarter of 2018, compared to 67 percent in the first-quarter of 2017.

7. Gummy divine.

For those who prefer to consume it using edibles, gummy candies reign supreme.

Fifty-four percent of respondents say they have consumed gummy candies in the past six months. Forty-nine percent say they have consumed baked goods, 44 percent say they’ve eaten chocolate candy and 36 percent say they’ve eaten hard candy in the past six months.

8. Topical.

Salves are the most preferred way to consume it by topical consumers, but lotions and creams also receive heavy usage. Thirty-four percent say salves or balms are the most preferred way to use it.

However, of those who have applied it topically in the past six months, lotions comes in at 45 percent, creams at 43 percent and salves or balms at 41 percent.

9. Where to buy?

Overwhelmingly, Colorado consumers prefer to purchase their marijuana from a dispensary, at 90 percent, compared to 88 percent in Q1 2017.

Debra BorchardtMay 6, 2018


This past Saturday the 47th Annual NYC Cannabis Parade and Rally attracted an enthusiastic crowd that openly smoked marijuana despite it being illegal in New York state. The rally was excited to have New York gubernatorial candidate Cynthia Nixon speak to the crowd at Union Square. It was also nice to see the women in cannabis represented at the event by the networking organization Women Grow and women-owned Etain Health.

Statements from other speakers were as follows:

NY State Senator Jesse Hamilton:
“Nine states and the District of Columbia have decided to legalize and regulate marijuana. By joining these states, New York would allow law enforcement to prioritize real public protection needs. Alongside broken windows policing, our outdated marijuana laws direct police resources, court time and the justice system’s authority at people who are not violent, not dangerous and do not pose a threat to the public. We must continue to work towards the day that New York rejects the deeply flawed policies of the past, embraces sensible reform and passes the Marijuana Regulation and Taxation Act.”
NY State Assembly Member Richard Gottfried:
“We need to move beyond the outdated and broken marijuana prohibition model
to a sensible tax-and-regulate system. But that’s only part of the solution.
Even in states with legal adult marijuana use, there is still evidence of unequal law enforcement practices targeting minority communities. We must ensure that those most victimized by the criminalization of marijuana benefit from the social and political progress around the issue, including reforming criminal justice processes and ensuring widespread participation in the marijuana business boom.”
NYC Council Member Jumaane Williams:
“We must expand out medical marijuana program to include all those who can benefit from its use,” adds Council Member Williams. “We also should rapidly move towards the full legalization of marijuana, expunge state criminal records of past users and create a pathway for all New Yorkers to benefit economically from this industry, not just a select few chosen by the Governor.”
NYC Council Member Donovan Richards:
“It’s a weird time when New York City finds itself to the right of former House Speaker John Boehner, but unfortunately that is where we are with about 17,000 marijuana arrests in 2017. We must stop the practice of flooding our prisons with marijuana offenders and disproportionally impacting communities of color now. Marijuana is not a threat to our public safety and our youth cannot wait any longer as one minor mistake can stick with them for the rest of their life”
Stuart Appelbaum, President of the Retail, Wholesale and Department Store Union (RWDSU):
“I have no doubt that recreational marijuana will soon be legal in New York – as it should be. The criminalization of marijuana has resulted in racial and social injustice because of its disparate enforcement and has denied its use as another tool in the war against opioid abuse. And we need to make sure that when it is legalized that workers in the industry are treated with dignity and respect, and have a union voice. The sooner marijuana is legalized the better.”


The event was founded by the Yippies (Youth International Party) in 1971. It has served as the flagship for the multi-decade mass movement for cannabis legalization and has taken place in various locations around the city over the years, including Washington Square Park, Battery Park and Dag Hammarskjold Plaza. The Event moved to Union Square Park in 2012. The mission of the event is to promote marijuana legalization federally and specifically in the New York Metro area, end discriminatory arrest practices and the mass incarceration of citizens and improve the state’s overly restricted medical cannabis program. The NYC Cannabis Parade & Rally is the founding chapter of the Global Marijuana March, which takes place in hundreds of cities in the U.S. and around the world in May and June.

William SumnerMarch 29, 2018


Cannabics Pharmaceuticals announced today that it has received positive results from a pre-clinical study on the anti-tumor effects of cannabinoids on cancerous tumor cells. Using cancer cells taken from patient blood samples, researchers found that the cells were sensitive in various ways to both THC and THCA, which are the main active compounds in cannabis.

To find this out, researchers isolated circulating tumor cells, which are cancer cells that have detached from the main tumor and circulate throughout the body, in blood samples taken from breast cancer and prostate cancer patients. They then treated the cells with either THC or THCA and then monitored cell viability over time.

Researchers found that the compounds had different cell killing effects based on the dosage, type of cancer, and the substance’s composition. In a statement, Dr. Eyal Ballan, Cannabics co-founder and chief technology officer, praised the study results.

“The results of this latest study further validate Cannabics’ ability to perform cannabinoid sensitivity tests on liquid biopsies and indicate in vitro antitumor activity of these compounds, which should be further examined in clinical studies. While the current use of medical cannabis is largely used for palliative purposes when it comes to cancer, we are seeing a growing number of clinical studies on the antitumor effects of cannabinoids and predict we will start to see eventual FDA approvals of cannabinoids to treat various types of cancer. Our goal is to support the personalization of these treatments with our drug sensitivity and therapy monitoring tests,” commented Ballan.

These latest results come as Israelis await a decision from the country’s embattled Prime Minister, Benjamin Netanyahu, as to the status of medical cannabis exports. Earlier in February, Netanyahu rejected moves to allow medical cannabis exports, sending the issue back to advisers for further assessment. Although Israel’s Agriculture, Finance, and Justice ministries are strongly in favor of the measure; it is unclear as to how Netanyahu will rule. A decision is expected in the coming weeks.

Debra BorchardtJanuary 12, 2018


Marijuana stocks continued the November rally into December as investors loaded up on stocks ahead of California’s legalized recreational sales. The U.S. Marijuana Index jumped 50% and the Canadian Marijuana Index climbed 65% for the month of December. Of course, this was all before the move by Sessions. Following that action, the North American Index fell from a high of 377 on January 9 to lately trading at a level of 327. The Canadian Index fell from a high of 1096 on Jan. 9 to 908 and the U.S. Index has fared the best only slipping from 103 on the ninth to just 100.

Aphria Inc. (APHQF) reported rising revenue and profits for the second quarter. Revenue for the three months ending November 30, 2017, was C$8,504 versus C$5,227 in the same period of the prior year, an increase of over 60% and C$6,120 in the first quarter of fiscal 2018, an increase of almost 40%. Gross profit for the second quarter was C$6,202, compared to C$4,121 in the same quarter in the prior year and C$7,904 in the previous quarter.

MedReleaf (MEDFF) announced a $100 million bought deal with Canaccord Genuity Corp. and GMP Securities. It is expected to close January 31. MedReleaf plans on using the net proceeds to finance construction of additional cannabis production and manufacturing facilities in Canada as well as in other jurisdictions with federal legal markets.

Origo Acquisition Corp. (OACQ) filed to change its name to High Times Media and convert from a Cayman Islands company to a Nevada corporation and change its symbol. Origo merged with High Times Holding Corp., the publisher of High Times Magazine in July of 2017. Following the merger, the company would like to be listed on the Nasdaq exchange under the symbol HITM.

And finally, Colorado said that in November dispensaries sold $119.6 million of cannabis products, a 9.5% increase over last year. Can’t wait to see what California dispensaries start reporting.

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up

About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


Recent Tweets

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.